Dramatic changes are occurring in the first decade of the 21st century. Rapid advances in science and technology are changing the way business and government are conducted. Some of the most important changes are occurring in the healthcare industry. This is having a dramatic impact on drug development and manufacturing. Drug development and time to market remain vital to business success in the pharmaceutical and biotechnology industries, but manufacturing efficiency has become equally important to future success and competitive advantage. Current manufacturing efficiency and quality standards are no longer acceptable.
Pharmaceutical crime and in particular the growing problem of trade in sub-standard counterfeit medicines, poses a serious threat to public health. Medicines need to be safe, effective and of good quality in order to produce the desired effect. Ensuring these properties in the face of threats from those involved in pharmaceutical crime requires not only vigilance on the part of national medicines regulatory bodies but greater collaborative links between international agencies concerned with the control of manufacture, importation, distribution and sale of medicines.
Never before in the history of mankind has the goal to live in a world without diseases been as real as it is today. The biggest obstacle to this goal is the resistance of the drug companies and the pharmaceutical industry, which base their business on the continuation of diseases.
Never before in the history of mankind has an industry risked the health and lives of millions of people longer and more systematically than the pharmaceutical industry. Its only goal is to make billions of dollars in profits from the continuous suffering and grief of millions of patients.
Never before in the history of mankind has there been a more comprehensive "deception business" than the pharmaceutical industry’s "business with disease." They promise “good health,” take billions of........